RevolKa
Latest round
- Series A
Last raised
- May 2025
Total raised
- $4.9M
Investors
- 4
About RevolKa
Founded in 2021 and based in Tokyo, Japan, Revolka Ltd. operates as a biotechnology research company that develops biopharmaceuticals using its proprietary artificial intelligence-based protein engineering technology. RevolKa specializes in protein engineering, utilizing its proprietary aiProtein® technology, which combines artificial intelligence with directed protein evolution. This technology accelerates the creation of engineered proteins and enables multi-dimensional modifications to enhance various properties, including efficacy and manufacturability of therapeutic antibodies. RevolKa is open to research collaborations and co-development opportunities related to its internal projects.
Who invested in RevolKa
4 investors across 3 rounds
See all investors in RevolKa
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about RevolKa
Who invested in RevolKa?
RevolKa has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RevolKa raised?
RevolKa has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did RevolKa last raise money?
RevolKa's most recent round on record is a Series A, in May 2025.
What does RevolKa do?
Founded in 2021 and based in Tokyo, Japan, Revolka Ltd.
Where is RevolKa headquartered?
RevolKa is headquartered in Tokyo, Japan.
Which VCs invest in companies like RevolKa?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at RevolKa's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like RevolKa? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.